AIROLDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 20.213
EU - Europa 11.449
AS - Asia 10.540
SA - Sud America 1.428
AF - Africa 245
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 11
Totale 43.922
Nazione #
US - Stati Uniti d'America 19.242
IT - Italia 3.620
SG - Singapore 3.029
CN - Cina 2.306
VN - Vietnam 2.272
DE - Germania 1.973
BR - Brasile 1.082
RU - Federazione Russa 1.031
HK - Hong Kong 1.021
SE - Svezia 863
CA - Canada 781
IE - Irlanda 563
PL - Polonia 553
GB - Regno Unito 538
FR - Francia 528
UA - Ucraina 421
IN - India 404
DK - Danimarca 366
BD - Bangladesh 307
FI - Finlandia 236
AT - Austria 168
TR - Turchia 158
ID - Indonesia 152
KR - Corea 149
ES - Italia 135
NL - Olanda 125
AR - Argentina 124
IQ - Iraq 115
JP - Giappone 108
MX - Messico 97
PK - Pakistan 95
ZA - Sudafrica 84
CH - Svizzera 75
PH - Filippine 58
SA - Arabia Saudita 55
UZ - Uzbekistan 52
EC - Ecuador 49
BE - Belgio 46
CL - Cile 42
RO - Romania 39
CO - Colombia 38
VE - Venezuela 33
EG - Egitto 29
LT - Lituania 29
PT - Portogallo 29
MY - Malesia 27
TW - Taiwan 27
AU - Australia 26
CZ - Repubblica Ceca 26
JO - Giordania 26
MA - Marocco 26
IR - Iran 25
PE - Perù 24
DZ - Algeria 22
ET - Etiopia 22
CR - Costa Rica 18
NP - Nepal 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
KE - Kenya 16
JM - Giamaica 15
LB - Libano 15
GR - Grecia 13
TH - Thailandia 13
AZ - Azerbaigian 11
BO - Bolivia 11
DO - Repubblica Dominicana 11
OM - Oman 11
PY - Paraguay 11
UY - Uruguay 11
IL - Israele 10
HN - Honduras 9
HU - Ungheria 9
PS - Palestinian Territory 9
SV - El Salvador 9
AL - Albania 8
BY - Bielorussia 8
EU - Europa 8
GE - Georgia 8
NZ - Nuova Zelanda 8
KZ - Kazakistan 7
NI - Nicaragua 7
RS - Serbia 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
LV - Lettonia 6
PA - Panama 6
SN - Senegal 6
SY - Repubblica araba siriana 6
CY - Cipro 5
KG - Kirghizistan 5
AM - Armenia 4
BH - Bahrain 4
EE - Estonia 4
GT - Guatemala 4
HR - Croazia 4
BB - Barbados 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
Totale 43.862
Città #
Ann Arbor 4.738
Singapore 1.819
Ashburn 1.621
Milan 1.398
Frankfurt am Main 1.233
San Jose 1.213
Woodbridge 1.000
Hong Kong 979
Wilmington 924
Fairfield 846
Chandler 751
Ho Chi Minh City 624
Houston 597
Dublin 541
Hanoi 533
Toronto 478
Kraków 476
Dallas 460
New York 415
Jacksonville 402
Beijing 387
Seattle 379
Santa Clara 349
Los Angeles 344
Dearborn 289
Cambridge 281
Chicago 229
Hefei 208
The Dalles 197
Princeton 196
Rome 176
Dong Ket 170
Columbus 137
Vienna 135
Guangzhou 134
Nanjing 130
Seoul 127
Boardman 125
Shanghai 125
Buffalo 124
Council Bluffs 120
Lauterbourg 118
São Paulo 115
Helsinki 111
Jakarta 93
Lawrence 87
Orem 85
Moscow 82
Da Nang 79
Altamura 78
Munich 70
Hangzhou 66
Montréal 64
Lachine 63
London 61
Brooklyn 60
Haiphong 60
Chennai 58
Tokyo 57
Kent 56
Montreal 55
San Diego 55
Nuremberg 53
Baghdad 52
Denver 52
Warsaw 52
Zurich 52
Tashkent 48
Ottawa 45
Tianjin 45
Biên Hòa 43
Nanchang 43
Brussels 41
Desio 40
Manchester 40
Stockholm 40
Florence 39
Changsha 38
Dhaka 38
Fremont 38
Ha Long 38
Johannesburg 38
Phoenix 38
Atlanta 37
Boston 37
Poplar 37
Andover 36
Grafing 36
Washington 36
Brescia 35
Paris 35
Shenyang 35
Amsterdam 33
Hải Dương 33
Turku 33
Mexico City 31
Naples 31
Parma 31
Ankara 30
Hyderabad 30
Totale 28.472
Nome #
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 807
Coffee variety, origin and extraction procedure: Implications for coffee beneficial effects on human health 762
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 753
Green coffee extract enhances oxidative stress resistance and delays aging in Caenorhabditis elegans 731
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 685
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 659
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 641
Xanthohumol destabilizes the structure of amyloid-β (Aβ) oligomers and promotes the formation of high-molecular-weight amorphous aggregates 636
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 630
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model 623
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 600
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 539
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 536
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 521
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model 521
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 507
Glycan carriers as glycotools for medicinal chemistry applications 507
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 506
Re LPS biogenetic pathway: Enzyme characterisation and synthetic efforts towards inhibitors 504
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide 493
Glycoconjugates in cancer therapy 492
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 475
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 472
Studies on the mechanism of action of a new class of inhibitors of Ras activation 470
Nuclear Magnetic Resonance as an Attractive Resource for Monitoring Surveillance Candidates of Acute and Chronic Lung Disorders 455
Flavonoids in the treatment of alzheimer’s and other neurodegenerative diseases 446
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 436
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium 415
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 404
Effectiveness of Vigna unguiculata seed extracts in preventing colorectal cancer 403
From cancer metabolism to new biomarkers and drug targets 401
How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode 395
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 392
Phosphonate Analogues of Arabinose 5-Phosphate: Putative Ligands for Arabinose 5-Phosphate Isomerases 390
New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface 385
Natural glycoconjugates with antitumor activity 384
Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors 384
Methionine supplementation stimulates mitochondrial respiration 379
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid b1-42 peptide 376
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 374
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 372
Targeting bacterial biofilm: a new LecA multivalent ligand with inhibitory activity 371
Flavonoids and their glycosides as anti-amyloidogenic compounds: Aβ1-42 interaction studies to gain new insights on their potential for Alzheimer's disease prevention and therapy 367
Metabolomic profiling of beers: Combining 1H NMR spectroscopy and chemometric approaches to discriminate craft and industrial products 366
1H NMR to Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification 364
Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease 358
Structural modifications of cis-glycofused benzopyran compounds and their influence on the binding to amyloid-β peptide 354
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 354
The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen 353
Towards a universal approach based on omics technologies for the quality control of food 352
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 351
Synthesis and biological evaluation of arabinose 5-phosphate mimics modified at position five 351
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3 349
Curcumin derivatives as new ligands of Aβ peptides 347
Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry 344
Targeting bacterial membranes: NMR spectroscopy characterization of substrate recognition and binding requirements of D-arabinose-5-phosphate isomerase 343
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 338
Carbohyrate scaffolds in chemical genetic studies 334
Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases 333
Curcumin derivatives: Aβ-ligands as potential diagnostic and therapeutic tools for alzheimer's disease 332
NMR Molecular Recognition Studies for the Elucidation of Protein and Nucleic Acid Structure and Function 330
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 330
Cheese-whey permeate improves the fitness of Escherichia coli cells during recombinant protein production 329
Antimicrobial peptides: Insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control 320
Targeting Bacterial Membranes: Identification of Pseudomonas aeruginosaD-Arabinose-5P Isomerase and NMR Characterisation of its Substrate Recognition and Binding Properties 311
On-cell NMR screening of multivalent ligands for bacterial targeting 308
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 306
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 306
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins 306
Fluorinated Arabinose-5-Phosphate Analogues as Potential Antibactericals 306
1H NMR to Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study 299
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 297
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 295
Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs 291
On-cell Saturation Transfer Difference NMR for the identification of FimH ligands and inhibitors 291
Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer's disease 284
Nutraceutical approach to increase healthy aging using Caenorhabditis elegans as a model organism 283
NMR Protein-Ligand Interaction Studies under Non-Homogeneous Conditions for Biomaterial Generation: A Model For Artificial Lectin-Carbohydrate Recognition 283
Cis-glyco-fused benzopyran compounds as new amyloid β peptide ligands 281
Tetracycline prevents Aβ oligomer toxicity through an atipical supramolecular interaction 281
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 280
Clustering Zwitterionic Amino Acids at the Upper Rim of Cone Calix[4]arene Triggers the Selective Recognition of Gram-Negative Bacterial Envelope 279
Solid-phase supported mimic of GDP-l-galactose 278
Development of new potential antitumor drugs based on Ras protein inhibition 274
Antarctic Soil Metabolomics: A Pilot Study 272
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers 264
Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1-42) 261
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 256
A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment 253
Synthesis of C- and S-Glycosides 252
Synthesis of 3-Deoxy-D-threopentofuranose 5-Phosphate, a Substrate of Arabinose 5-Phosphate Isomerase 251
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment 248
Sugar-Based Enantiomeric and Conformationally Constrained Pyrrolo[2,1-c][1,4]-Benzodiazepines as Potential GABAALigands 248
Aβ Monomers, Oligomers and Fibrils: Structural Features 245
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 244
New C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. Therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents 240
Adjuvant Effect of Cinnamon Polyphenolic Components in Colorectal Cancer Cell Lines 238
Saturation Transfer Difference NMR Experiments of Membrane Proteins in Living Cells under HR-MAS Conditions: the Interaction of the SGLT1 Co-transporter with Its Ligands 237
Phytotoxicity, nematicidal activity and chemical constituents of Peucedanum ostruthium (L.) W.D.J.Koch (Apiaceae) 235
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 234
Totale 38.648
Categoria #
all - tutte 123.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.283 308 342 310 309 161 271 222 154 283 246 273 404
2022/20233.845 497 937 478 362 324 509 126 195 194 57 98 68
2023/20242.402 102 118 156 187 266 476 373 131 181 68 99 245
2024/20255.929 277 575 515 307 422 272 279 228 590 874 539 1.051
2025/202615.972 2.057 1.111 1.263 1.700 1.696 716 2.334 622 1.107 1.332 837 1.197
2026/2027140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 45.015